Dan McLaughlin is a Brisbane neurologist and epileptologist. He worked in Professor Mervyn Eadie’s Neuropharmacology unit developing an interest in the pharmacology of antiseizure medications. This led to the opportunity to participate as a clinical investigator in a number of international multicentre clinical trials of emerging antiseizure drugs. Currently he is chair of the Epilepsy Society of Australia’s Drugs and Devices sub-committee.